Zoetis Inc. (NYSE:ZTS) Shares Sold by TrinityPoint Wealth LLC

TrinityPoint Wealth LLC lessened its stake in shares of Zoetis Inc. (NYSE:ZTS) by 5.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 37,183 shares of the company’s stock after selling 1,939 shares during the quarter. Zoetis comprises about 1.0% of TrinityPoint Wealth LLC’s investment portfolio, making the stock its 20th biggest holding. TrinityPoint Wealth LLC’s holdings in Zoetis were worth $7,265,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ZTS. Cetera Investment Advisers boosted its position in shares of Zoetis by 275.2% during the 1st quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock valued at $16,259,000 after purchasing an additional 70,476 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in Zoetis by 49.6% during the first quarter. Acadian Asset Management LLC now owns 25,051 shares of the company’s stock worth $4,235,000 after buying an additional 8,302 shares in the last quarter. Soltis Investment Advisors LLC acquired a new position in Zoetis in the first quarter worth approximately $688,000. Bank Pictet & Cie Asia Ltd. increased its holdings in shares of Zoetis by 41.0% in the second quarter. Bank Pictet & Cie Asia Ltd. now owns 37,500 shares of the company’s stock valued at $6,501,000 after buying an additional 10,900 shares in the last quarter. Finally, Simplify Asset Management Inc. acquired a new stake in shares of Zoetis during the 3rd quarter valued at $11,684,000. Institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on ZTS shares. BTIG Research boosted their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. JPMorgan Chase & Co. upped their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus lifted their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Piper Sandler lifted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $221.44.

Zoetis Trading Up 0.3 %

Zoetis stock opened at $175.14 on Monday. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The stock has a market cap of $79.02 billion, a P/E ratio of 32.92, a P/E/G ratio of 2.69 and a beta of 0.90. The company’s fifty day simple moving average is $187.09 and its 200-day simple moving average is $180.38.

Zoetis (NYSE:ZTS) last issued its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. During the same quarter in the previous year, the company posted $1.36 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be paid a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.